Biofocus Chemosentivity Testing

Biofocus is a laboratory in Germany that offers a chemosentivity test that allows you to know which chemotherapeutic agents will work most effectively against your particular cancer cells. My results are due back in 1-2 weeks, and I can't tell you how excited I am to soon have this knowledge as a resource in my cancer management plan. The traditional approach is to make the patient the petri dish, and see over time--sometimes 6 months per drug if not longer--if a chemotherapy drug works. The Biofocus kind of testing in a matter of 2-3 weeks accelerates the knowledge that might otherwise take years to discover if the patient continues to remain the petri dish. Let the lab technicians first do their testing to see what works, and then jump ahead of wasted months to years of ineffective therapies--and cancer patients most often do no have that kind of time.

We all talk about biochemical individuality, but cancer therapy does not incorporate it unless this kind of testing is done for each cancer patient. And, such a test would save money for the healthcare industry, because patients would arrive at the correct drugs faster. It boggles the mind how such testing is not a standard part of cancer care.

Think of this kind of testing as a kind of GPS for your cancer drugs. You will arrive at the place you want to be more directly and faster. There are other places that offer this kind of testing as well, and I cannot say which test is best. But some sort of testing for chemo drug efficacy should be done for all cancer patients if we truly want to call the medicine we practice in this country both compassionate and state-of-the-art.